The role of Cyfip1 in platelet formation and function

The Cytoplasmic FMR1 Interacting Protein 1 (Cyfip1) is member of the highly conserved pentameric WASP family Verprolin-homologous protein (WAVE) regulatory complex 2 (WRC2), which plays in eukaryotic cells a pivotal role in regulating lamellipodia formation through actin cytoskeleton modulation. Its function in platelets, particularly in relation to thrombosis and hemostasis, is largely unexplored. To investigate this, a conditional knockout mouse model was generated, specifically lacking Cyfip1 in megakaryocytes and platelets. A comparison was made with platelets treated with CK-0944666 (CK-666), an inhibitor of the Arp2/3 complex, and Cytochalasin D, an inhibitor of actin polymerisation in order to further differentiate the phenotype. The conditional knockout of Cyfip1 resulted in platelets exhibiting an inability to form lamellipodia, yet surprisingly, it did not significantly affect other fundamental platelet functions. Platelet count, size, resting morphology and ultrastructure remained unchanged. Despite the absence of lamellipodia, platelets showed normal activation, aggregation, and thrombus formation in vitro. This suggests that although Cyfip1 is essential for lamellipodia formation, its absence does not critically impair these key platelet functions. Platelet treatment with CK-666 mimicked the Cyfip1 knockout phenotype in terms of reduced lamellipodia formation, but did not fully abolish it and caused other undesired side effects. In conclusion, while Cyfip1 is integral to lamellipodia formation in platelets, its absence does not significantly impair key platelet functions, challenging previously still held assumptions about the role of lamellipodia in platelet physiology. This suggests a possible compensatory mechanism or redundancy in platelet cytoskeletal dynamics. The precise mechanisms and implications of this redundancy, however, remain to be fully elucidated.